Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2025 08:00 ET | Source: Gate Bioscience

Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

Gate Bioscience closes $65M Series B to advance molecular gates, oral drugs that eliminate disease proteins, into clinical trials for CNS/inflammation
November 01, 2022 06:02 ET | Source: Jeito Capital

Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases

Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with...